Acarbose Add-on Therapy in Patients with Type 2 Diabetes Mellitus with Metformin and Sitagliptin Failure: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study

BACKGROUND: We evaluated the efficacy and safety of acarbose add-on therapy in Korean patients with type 2 diabetes mellitus (T2DM) who are inadequately controlled with metformin and sitagliptin. METHODS: A total of 165 subjects were randomized to metformin and sitagliptin (Met+Sita, n=65), metformi...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Hae Kyung, Lee, Seung-Hwan, Shin, Juyoung, Choi, Yoon-Hee, Ahn, Yu-Bae, Lee, Byung-Wan, Rhee, Eun Jung, Min, Kyung Wan, Yoon, Kun-Ho
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Diabetes Association 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6581543/
https://www.ncbi.nlm.nih.gov/pubmed/30604599
http://dx.doi.org/10.4093/dmj.2018.0054

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6581543/
https://www.ncbi.nlm.nih.gov/pubmed/30604599
http://dx.doi.org/10.4093/dmj.2018.0054

Ejemplares similares